Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting

被引：7

作者：

Holland, Richard ^{[1
]}

Tillett, William ^{[2
]}

Ogdie, Alexis ^{[3
]}

Leung, Ying Y. ^{[4
]}

Gladman, Dafna D. ^{[5
]}

Duffin, Kristina Callis ^{[6
]}

Coates, Laura C. ^{[7
]}

Mease, Philip J. ^{[8
,9
]}

Eder, Lihi ^{[10
]}

Strand, Vibeke ^{[11
]}

Elmamoun, Musaab ^{[12
,13
]}

Hojgaard, Pil ^{[14
]}

Chau, Jeffrey ^{[15
]}

de Wit, Maarten ^{[16
]}

Goel, Niti ^{[17
]}

Lindsay, Chris A.

FitzGerald, Oliver ^{[13
]}

Shea, Bev ^{[18
,19
]}

Beaton, Dorcas ^{[20
,21
,22
,23
]}

Orbai, Ana-Maria ^{[24
]}

机构：

[1] Royal Prince Alfred Hosp, Med Ctr, Sydney, Australia

[2] Royal Natl Hosp Rheumat Dis, Bath, England

[3] Univ Penn, Philadelphia, PA USA

[4] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore

[5] Univ Toronto, Univ Hlth Network, Krembil Res Inst, Psoriat Arthrit Program, Toronto, ON, Canada

[6] Univ Utah, Dept Dermatol, Salt Lake City, UT USA

[7] Univ Oxford, Oxford, England

[8] Swedish Med Ctr, Rheumatol Res, Seattle, WA USA

[9] Univ Washington, Sch Med, Seattle, WA USA

[10] Univ Toronto, Womens Coll Res Inst, Womens Coll Hosp, Toronto, ON, Canada

[11] Stanford Univ, Div Immunol Rheurnatol, Palo Alto, CA 94304 USA

[12] St Vincents Univ Hosp, Dept Rheumatol, Dublin, Ireland

[13] Univ Coll Dublin, Conway Inst Biomol Res, Dublin, Ireland

[14] Bispebjerg & Frederiksberg Hosp, Parker Inst, Copenhagen, Denmark

[15] Hong Kong Psoriat Arthrit Assoc, Hong Kong, Hong Kong, Peoples R China

[16] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands

[17] Duke Univ, Sch Med, IQVIA, Durham, NC USA

[18] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Fac Med, Ottawa, ON, Canada

[19] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada

[20] Univ Toronto, Musculoskeletal Hlth & Outcomes Res, St Michaels Hosp, Toronto, ON, Canada

[21] Univ Toronto, Inst Work & Hlth, Toronto, ON, Canada

[22] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Rehabil Sci Inst, Toronto, ON, Canada

[23] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada

[24] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA

来源：

JOURNAL OF RHEUMATOLOGY | 2018年 / 45卷 / 06期

基金：

美国国家卫生研究院;

关键词：

PSORIASIS; PSORIATIC ARTHRITIS; GRAPPA; OUTCOME MEASURES IN RHEUMATOLOGY; CORE SET; QUESTIONNAIRE; VALIDATION;

D O I：

10.3899/jrheum.180142

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPAV)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group is in the process of selecting core instruments for PsA clinical trials. During a 2-h workshop and breakout group discussions at the GRAPPA 2017 annual meeting in Amsterdam, the Netherlands, participants discussed the first sel of candidate instruments to be taken through the OMERACT Filter 2.1 instrument selection process: 66/68 swollen/tender joint count (66/68JC), Spondyloarthritis Consortium of Canada (SPARCC) enthesitis index, patient's global assessment (GRAPPA and OMERACT formulations), Health Assessment Questionnaire Disability Index (HAQ-DI), Psoriatic Arthritis Impact of Disease (PsAID) questionnaires 9 and 12, and Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue. Based on the assessment of domain match (content and face validity) and feasibility according lo the OMERACT instrument selection criteria, the working group recommends continuing with appraisal of construct validity and discrimination for 66/68JC, SPARCC, PsAID 9 and 12. HAQ-DI, and FACIT-Fatigue. In addition, it recommends repeating the OMERACT Filter 2.1 process for patient global instruments because of insufficient votes. Additional sets of candidate instruments for the PsA core instrument set will be evaluated in a similar process.

引用

页码：17 / 25

页数：9

共 15 条

[1]

[Anonymous], The OMERACT Handbook

[2] Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 [J].

Boers, Maarten ;

Kirwan, John R. ;

Wells, George ;

Beaton, Dorcas ;

Gossec, Laure ;

d'Agostino, Maria-Antonietta ;

Conaghan, Philip G. ;

Bingham, Clifton O., III ;

Brooks, Peter ;

Landewe, Robert ;

March, Lyn ;

Simon, Lee S. ;

Singh, Jasvinder A. ;

Strand, Vibeke ;

Tugwell, Peter .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (07) :745-753

[3] Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study [J].

Cauli, Alberto ;

Gladman, Dafna D. ;

Mathieu, Alessandro ;

Olivieri, Ignazio ;

Porru, Giovanni ;

Tak, Paul P. ;

Sardu, Claudia ;

Ujfalussy, Ilona ;

Scarpa, Raffaele ;

Marchesoni, Antonio ;

Taylor, William J. ;

Spadaro, Antonio ;

Fernandez-Sueiro, Jose L. ;

Salvarani, Carlo ;

Kalden, Joachim R. ;

Lubrano, Ennio ;

Carneiro, Sueli ;

Desiati, Francesca ;

Flynn, John A. ;

D'Angelo, Salvatore ;

Vacca, Alessandra ;

Van Kuijk, Arno W. R. ;

Catanoso, Maria Grazia ;

Gruenke, Mathias ;

Peluso, Rosario ;

Parsons, Wendy J. ;

Ferrara, Nicola ;

Contu, Paolo ;

Helliwell, Philip S. ;

Mease, Philip J. .

JOURNAL OF RHEUMATOLOGY, 2011, 38 (05) :898-903

[4] Fatigue in cancer patients compared with fatigue in the general United States population [J].

Cella, D ;

Lai, JS ;

Chang, CH ;

Peterman, A ;

Slavin, M .

CANCER, 2002, 94 (02) :528-538

[5] THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY CORE SET OF DISEASE-ACTIVITY MEASURES FOR RHEUMATOID-ARTHRITIS CLINICAL-TRIALS [J].

FELSON, DT ;

ANDERSON, JJ ;

BOERS, M ;

BOMBARDIER, C ;

CHERNOFF, M ;

FRIED, B ;

FURST, D ;

GOLDSMITH, C ;

KIESZAK, S ;

LIGHTFOOT, R ;

PAULUS, H ;

TUGWELL, P ;

WEINBLATT, M ;

WIDMARK, R ;

WILLIAMS, HJ ;

WOLFE, F .

ARTHRITIS AND RHEUMATISM, 1993, 36 (06) :729-740

[6]

FRIES JF, 1982, J RHEUMATOL, V9, P789

[7]

Gladman DD, 2007, J RHEUMATOL, V34, P1167

[8] A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative [J].

Gossec, Laure ;

de Wit, Maarten ;

Kiltz, Uta ;

Braun, Juergen ;

Kalyoncu, Umut ;

Scrivo, Rossana ;

Maccarone, Mara ;

Carton, Laurence ;

Otsa, Kati ;

Sooaeaer, Imre ;

Heiberg, Turid ;

Bertheussen, Heidi ;

Canete, Juan D. ;

Lombarte, Anselm Sanchez ;

Balanescu, Andra ;

Dinte, Alina ;

de Vlam, Kurt ;

Smolen, Josef S. ;

Stamm, Tanja ;

Niedermayer, Dora ;

Bekes, Gabor ;

Veale, Douglas ;

Helliwell, Philip ;

Parkinson, Andrew ;

Luger, Thomas ;

Kvien, Tore K. .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) :1012-1019

[9]

Hojgaard P, 2017, SEMIN ARTHRITIS RHEU

[10] Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index [J].

Maksymowych, W. P. ;

Mallon, C. ;

Morrow, S. ;

Shojania, K. ;

Olszynski, W. P. ;

Wong, R. L. ;

Sampalis, J. ;

Conner-Spady, B. .

ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) :948-953

← 1 2 →